The effectiveness of Reslizumab in severe asthma treatment: a real-world experience

BACKGROUND: Increased numbers of blood and sputum eosinophils are associated with higher exacerbation frequency and increased asthma severity. In clinical trials, targeting Interleukin-5 has been shown to be a useful therapeutic strategy for patients with severe eosinophilic asthma. METHODS: Twenty-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, H., O’Sullivan, R., Casey, D., Murphy, J., MacSharry, J., Plant, B. J., Murphy, D. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923853/
https://www.ncbi.nlm.nih.gov/pubmed/31861993
http://dx.doi.org/10.1186/s12931-019-1251-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923853/
https://www.ncbi.nlm.nih.gov/pubmed/31861993
http://dx.doi.org/10.1186/s12931-019-1251-3

Ejemplares similares